DPD-Deoxypyridinoline (Pyrilinks D) Urine

It is used to monitor the re-absorption rate of the bone. It is used for:

• Diagnosis of osteoporosis along with other blood parameters
• In post-menopausal and early menopausal women with lack of estrogen levels which increases the risk of osteoporosis.
• Monitoring in post menopausal women diagnosed with osteoporosis and receiving antiresorptive therapy.
• In other disorders where the bone density is found to be affected. 

• DPD in the urine is a sensitive marker for bone resorption screening and monitoring. It is a tool to diagnose metabolic bone diseases, which impact bone turnover in key populations, particularly postmenopausal women. DPD enters the bloodstream during bone resorption and is eliminated from the body, unmetabolized in the urine. The levels are affected by certain conditions that affect bone resorption rates. Urine DPD levels reflect the rate of bone turnover.

• It is used to diagnose osteoporosis in conjunction with other blood parameters.
• In postmenopausal and early menopausal women, low estrogen levels increase the risk of osteoporosis.
• To diagnose bone diseases such as postmenopausal osteoporosis, bone metastasis, and Paget's disease.
• Other conditions where bone density is found to be compromised.
• As a follow-up in postmenopausal women with osteoporosis who are receiving antiresorptive therapy

The test measures the level of Deoxypyridinoline(DPD) in the urine. 

10 ml of Spot Urine In Dark Leak Proof Container without preservative.

High DPD levels in urine indicate the risk of osteoporosis due to poor bone re-absorption status. 
This is most commonly seen in post menopausal women with low estrogen levels. 

Osteoporosis has no symptoms in its early stages. The only way to find out if you have bone resorption is to have it tested. The absence of symptoms does not guarantee that you are not experiencing bone resorption.

The DPD test is available to anyone who is healthy or exhibits the previously described symptoms. It is a screening test for determining bone resorption rate.

• To assess bone resorption rates in healthy people.

Individuals who are at a high risk of developing metabolic bone diseases

There are no specific instructions for this test. You need to inform the doctor about any medications you are currently taking. No fasting is required unless there is another test for which you are providing a sample.

In addition to the DPD test, other bone markers, such as alkaline phosphatase, osteocalcin, and N-terminal telopeptide tests, may be recommended

• This procedure will only check for the presence of DPD in the given urine sample.
• Because the laboratory data has limited diagnostic value, your doctor may suggest additional laboratory tests in addition to this one.
• This test does not predict osteoporosis development or the likelihood of future fractures.

Yes! You can download your test report by visiting our website and logging in.

High DPD levels in the urine indicate an increased risk of osteoporosis due to impaired bone resorption. This is most common in postmenopausal women who have low estrogen levels.

The deoxypyridinoline test is just like any other urine test. A lab technician visits your home to collect the sample. Book your tests through our website.

• Post-menopausal women and men after age 50
• Rheumatoid arthritis
• Low body weight
• Hormone deficiency
• Inactive lifestyle
• A lifetime diet low in calcium and vitamin D
• Calcium and vitamin D deficiency
• Long-term use of steroid therapy
• Chronic inflammatory bowel disease
• Autoimmune diseases
• Stroke history
• Excessive alcohol consumption
• Diminished muscle mass

DPD

D-Pyrilinks

Pyrilinks-D

deoxyPYD

DPD cross-link

Urine DPD

Urinary crosslinks DPD

Pyridinium (urine) collagen cross-link